Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy

Zhou Shu-Juan; Wang Si-Qian; Ma Yong-Yong; Tang Li-Yuan; Shi Yi-Fen; Liang Bin; Chen Yi; Yu Kang

首页> 外文期刊>Hematology. >Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy

【24h】

Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy

机译：质子泵抑制剂与化疗后血液系统恶性肿瘤患者肠道源性菌血症发生的关系

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Gut-derived bacteraemia is a major complication in patients with haematological malignancy after chemotherapy.

机译：背景：肠道源性菌血症是化疗后血液系统恶性肿瘤的主要并发症。

著录项

来源
《Hematology.》 |2016年第6期|共6页
作者
Zhou Shu-Juan; Wang Si-Qian; Ma Yong-Yong; Tang Li-Yuan; Shi Yi-Fen; Liang Bin; Chen Yi; Yu Kang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词
Hematologic malignancy; Gut-derived bacteraemia; Proton pump inhibitor (PPI); Prophylactic antibiotics;

机译：血液系统恶性;肠源性菌血症;质子泵抑制剂（PPI）;预防性抗生素;

相似文献

外文文献
中文文献
专利

1. Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy [J] . Zhou Shu-Juan, Wang Si-Qian, Ma Yong-Yong, Hematology. . 2016,第6期

机译：质子泵抑制剂与化疗后血液系统恶性肿瘤患者肠道源性菌血症发生的关系
2. Co‐administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed‐released tablets in adult patients with haematological malignancies [J] . Cojutti Pier Giorgio, Candoni Anna, Lazzarotto Davide, British Journal of Clinical Pharmacology . 2018,第11期

机译：质子泵抑制剂和/或类固醇的共同施用可能是病原体患者在血液恶性肿瘤的成年患者中低谷浓度的低槽浓度的危险因素
3. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies. [J] . Todeschini G, Tecchio C, Borghero C, Journal of Infection . 2006,第4期

机译：嗜中性白血球缺乏症血液系统恶性肿瘤患者肠球菌菌血症与死亡之间的关系。
4. Association of Multi-Drug Resistance-1 (MDR1) Gene Polymorphism with Leukocytopenia in Breast Cancer Patients treated with Chemotherapy [C] . Siti Syarifah, Tri Widyawati, Kamal B. Siregar, Public Health International Conference . 2017

机译：化疗治疗乳腺癌患者白细胞凋亡的多药抗性-1（MDR1）基因多态性的关联
5. Lack of Association between Out-of-Hospital Use of Proton Pump Inhibitors and Hypomagnesemia at Hospital Admission: A Nested Case-Control Study. [D] . Koulouridis, Ioannis. 2012

机译：医院入院时质子泵抑制剂在院外使用与低镁血症之间缺乏关联：嵌套病例对照研究。
6. Co‐administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed‐released tablets in adult patients with haematological malignancies [O] . Pier Giorgio Cojutti, Anna Candoni, Davide Lazzarotto, 2018

机译：成年血液系统恶性肿瘤患者中并用质子泵抑制剂和/或类固醇可能是泊沙康唑缓释片低谷浓度的危险因素
7. Association between use of proton pump inhibitors and occurrence of colon diverticulitis [O] . Bo-Lung Ho, Hsiao-Yun Hu, Shen-Shong Chang 2016

机译：质子泵抑制剂的使用与结肠憩室炎的发生之间的关系

Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅